Abstract
Objectives
The present study investigates the effect of anosognosia (impaired insight for an illness) and cognitive deficits on the reliability and validity of self-rated Quality of Life (QoL) in Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD).
Design
Cross-sectional study.
Setting
Cross-sectional study with a consecutive clinical sample from a memory clinic in Leipzig (Germany).
Subjects
27 patients (aged 65 years or above) with a diagnosis of either MCI (N=12) or AD (N=15), each together with a caregiver.
Measurements
The patients’ QoL was measured using the Dementia Quality of Life self and proxy ratings (DEMQoL and DEMQoLproxy). The degree of anosognosia was rated by means of the Clinical Insight Rating Scale (CIR). In addition the Mini-Mental-State Examination (MMSE), and for diagnostic purposes the Bayer Activities of Daily Living Scale (B-ADL) and the Consortium to Establish a Registry of Alzheimer’s Disease (CERAD) word list were applied.
Results
In accordance with the results of Ready et al. (1), patients with impaired insight were found to produce less reliable QoL ratings than those with unimpaired insight. The validity (concordance between self- and proxy QoL ratings) is influenced by cognitive deficits, anosognosia and the interaction between these factors.
Conclusions
Data which are based on dementia patients’ QoL self-ratings need to be interpreted with caution when anosognosia is present.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ready RE, Ott BR, Grace J. Insight and cognitive impairment: effects on quality-of-life reports from mild cognitive impairment and Alzheimer’s disease patients. Am J Alzheimers Dis Other Demen 2006;21:242–248.
European Medinices Agency (EMEA). Guidelines on medical products for the treatment of Alzheimer’s disease and other dementias http://www.emea.europa.eu/pdfs/human/ewp/055395en.pdf 2008. Accessed October 9, 2008.
Gertz HJ, Berwig M. [Critical observations on measuring quality of life of persons suffering from dementia:]. Nervenarzt 2008;79:1023–1035.
Lawton MP. Quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord 1994;8Suppl 3:138–150.
Jonker C, Gerritsen DL, Bosboom PR et al. A model for quality of life measures in patients with dementia: Lawton’s next step. Dement Geriatr Cogn Disord 2004;18:159–164.
Noll H-H. Social Indicators and Social Reporting: The International Experience. http://www.ccsd.ca/noll1.html 2000. Accessed October 8, 2008.
Dilling H, Mombour W, Schmidt H et al. Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F): Forschungskriterien. Bern: Huber, 1994.
WHO. International Classification of Diseases 10th Revision (ICD-10). http://www.who.int/classifications/apps/icd/icd10online/2007. Accessed October 9, 2008.
Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State — Practical Method for Grading Cognitive State of Patients for Clinician. Journal of Psychiatric Research 1975;12:189–198.
Petersen RC, Stevens JC, Ganguli M et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–1142.
Thalmann B, Monsch AU, Schneitter M et al. Die CERAD Neuropsychologische Testbatterie: Ein gemeinsames minimales Instrumentarium zur Demenzabklärung 2007.
Hindmarch I, Lehfeld H, de Jongh P et al. The Bayer activities of daily living scale (B-ABL). Dementia and Geriatric Cognitive Disorders 1998; 9:20–26.
Smith SC, Lamping DL, Banerjee S et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess 2005;9:1–93, iii–iv.
Brod M, Stewart AL, Sands L et al. Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist 1999; 39:25–35.
Knorr C, Fröhlich L. What determines health related quality of life (HRQOL) in patients with dementia and their caregivers?. 2007 International Society for Quality of Life Research meeting abstracts [http://www.isoqol.org/2007mtgabstracts.pdf]. Quality of Life Research supplement A-116, Abstract #1636 2007.
Ott BR, Fogel BS. Measurement of Depression in Dementia: Self vs Clinician Rating. International Journal of Geriatric Psychiatry 1992;7:899–904.
Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessement instruments in psychology. Psychol Assess 1994;6:284–290.
Clare L. Awareness in early-stage Alzheimer’s disease: a review of methods and evidence. Br J Clin Psychol 2004;43:177–196.
Charter RA, Feldt LS. Testing the equality of two alpha coefficients. Percept Motor Skills 1996;82:763–768.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berwig, M., Leicht, H. & Gertz, H.J. Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer’s disease — Further evidence for the impact of anosognosia and global cognitive impairment. J Nutr Health Aging 13, 226–230 (2009). https://doi.org/10.1007/s12603-009-0063-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-009-0063-4